Literature DB >> 26407512

Electrocardiogram and Chagas disease: a large population database of primary care patients.

Milena S Marcolino1, Daniel M Palhares2, Lorena R Ferreira2, Antonio L Ribeiro2.   

Abstract

BACKGROUND: Chagas disease (ChD) used to be a disease restricted to Latin America, but has become a worldwide problem due to migration of infected individuals to developed countries. Electrocardiography has been considered an essential exam to evaluate ChD patients.
OBJECTIVE: This study sought to identify prevalent electrocardiographic abnormalities in a large sample of ChD patients evaluated in the primary care setting.
METHODS: This retrospective observational study assessed all consecutive digital 12-lead electrocardiograms (ECG) performed by the Telehealth Network of Minas Gerais, Brazil, from January 1 to December 31, 2011. In that time, the service attended primary care patients in 660 cities in the Minas Gerais province. ChD was self-reported, and the individuals who did not report having ChD were considered noninfected. The prevalence of electrocardiographic abnormalities was assessed.
RESULTS: Self-reported ChD patients comprised 7,590 (2.9%) of 264,324 patients who underwent ECG during the study period. The mean age for ChD patients was 57.0 ± 13.7 years, and 64.1% of patients were women. The most common comorbidities were hypertension (61.3%), diabetes (9.1%), and dyslipidemia (6.9%), and 10.7% were smokers. The most frequent electrocardiographic abnormalities were nonspecific repolarization abnormalities (34.6%), right bundle branch block (RBBB) (22.7%), left anterior hemiblock (LAH) (22.5%), ventricular premature beats (5.4%), and atrial fibrillation (5.4%). Only 31.5% of the patients had no electrocardiographic abnormality versus 61.2% in noninfected individuals (p < 0.001). The prevalence of normal ECG decreased with aging and was significantly lower than for noninfected individuals in all age groups. Pacemaker rhythm (odds ratio [OR]: 13.3, 95% confidence intervals [CI]: 11.5 to 15.4), RBBB (OR: 10.7, 95% CI: 10.1 to 11.4), especially in association with LAH (OR: 12.1, 95% CI: 11.2 to 13.0), second atrioventricular block (OR: 4.1, 95% CI: 2.5 to 6.6), and third atrioventricular block (OR: 13.3, 95% CI: 11.5 to 15.4) were strongly related to ChD.
CONCLUSIONS: In this large sample of primary care patients with ChD, there was a high prevalence of electrocardiographic abnormalities. Pacemaker rhythm, RBBB, especially in association with LAH, and second and third atrioventricular block were strongly related to ChD.
Copyright © 2015 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26407512     DOI: 10.1016/j.gheart.2015.07.001

Source DB:  PubMed          Journal:  Glob Heart


  15 in total

1.  Cardiovascular Statistics - Brazil 2021.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

Review 2.  Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

Authors:  Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina
Journal:  Pathogens       Date:  2021-04-22

3.  Cardiovascular Statistics - Brazil 2020.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Andreia Biolo; Bruno Ramos Nascimento; Deborah Carvalho Malta; Maria de Fatima Marinho de Souza; Gabriel Porto Soares; Gesner Francisco Xavier Junior; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Odilson Marcos Silvestre; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

4.  Comparison of Noninvasive Cardiac Test Strategies for Newly Diagnosed Chagas Disease in a Non-Endemic Zone.

Authors:  Elena Refoyo; Jesús Troya; Elena Trigo; Gabriela Guzmán-Martinez; Silvia Valbuena-López; Juan Caro-Codón; Sandra Rosillo; Mar Moreno-Yanguela; Juan Tamargo; José Ramón Arribas; Harry Acquatella; José Lopez-Sendon
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

5.  Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil.

Authors:  Ariela Mota Ferreira; Ester Cerdeira Sabino; Lea Campos de Oliveira; Cláudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Antônio Luiz Pinho Ribeiro; Desirée Sant'Ana Haikal
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

Review 6.  Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Authors:  Ayrton R Massaro; Gregory Y H Lip
Journal:  Arq Bras Cardiol       Date:  2016-08-11       Impact factor: 2.000

7.  Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort.

Authors:  Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Roberto Magalhães Saraiva; Luiz Henrique Conde Sangenis; Marcelo Teixeira de Holanda; Henrique Horta Veloso; Andrea Rodrigues da Costa; Fernanda de Souza Nogueira Sardinha Mendes; Pedro Emmanuel Alvarenga Americano do Brasil; Gilberto Marcelo Sperandio da Silva; Mauro Felippe Felix Mediano; Andrea Silvestre de Sousa
Journal:  Trop Med Infect Dis       Date:  2020-05-12

8.  Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile.

Authors:  Clareci Silva Cardoso; Ester Cerdeira Sabino; Claudia Di Lorenzo Oliveira; Lea Campos de Oliveira; Ariela Mota Ferreira; Edécio Cunha-Neto; Ana Luiza Bierrenbach; João Eduardo Ferreira; Desirée Sant'Ana Haikal; Arthur L Reingold; Antonio Luiz P Ribeiro
Journal:  BMJ Open       Date:  2016-05-04       Impact factor: 2.692

9.  Risk Score for Predicting 2-Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi-Trop Cohort Study.

Authors:  Claudia Di Lorenzo Oliveira; Maria Carmo P Nunes; Enrico Antonio Colosimo; Emilly Malveira de Lima; Clareci S Cardoso; Ariela Mota Ferreira; Lea Campos de Oliveira; Carlos Henrique Valente Moreira; Ana Luiza Bierrenbach; Desireé Sant Ana Haikal; Sérgio Viana Peixoto; Maria Fernanda Lima-Costa; Ester Cerdeira Sabino; Antonio Luiz P Ribeiro
Journal:  J Am Heart Assoc       Date:  2020-03-11       Impact factor: 5.501

Review 10.  WHF IASC Roadmap on Chagas Disease.

Authors:  Luis Eduardo Echeverría; Rachel Marcus; Gabriel Novick; Sergio Sosa-Estani; Kate Ralston; Ezequiel Jose Zaidel; Colin Forsyth; Antonio Luiz P RIbeiro; Iván Mendoza; Mariano Luis Falconi; Jorge Mitelman; Carlos A Morillo; Ana Cristina Pereiro; María Jesús Pinazo; Roberto Salvatella; Felipe Martinez; Pablo Perel; Álvaro Sosa Liprandi; Daniel José Piñeiro; Gustavo Restrepo Molina
Journal:  Glob Heart       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.